Downregulation of vaccinia virus intermediate and late promoters by host transcription factor YY1

Journal of General Virology

Volumn 90, Issue 7, 2009, Pages 1592-1599

  Knutson, Bruce A ^a,b   Oh, Jaewook ^a,c   Broyles, Steven S ^a  

^a PURDUE UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR YY1; TRANSCRIPTION FACTOR; VIRUS DNA; YY1 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DNA BINDING; DOWN REGULATION; GENE DELETION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; VACCINIA VIRUS; VIROGENESIS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; REGULATORY SEQUENCE;

VACCINIA VIRUS;

DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HELA CELLS; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VACCINIA VIRUS; YY1 TRANSCRIPTION FACTOR;

EID: 67849095677     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.006924-0     Document Type: Article

References (32)

1. Austen, M., Cerni, C., Lüscher-Firzlaff, J. M. & Lüscher, B. (1998). YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene 17, 511-520.
2. Baldick, C. J., Jr, Keck, J. G. & Moss, B. (1992). Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. J Virol 66, 4710-4719.
3. Bertholet, C., Van Meir, E., ten Heggeler-Bordier, B. & Wittek, R. (1987). Vaccinia virus produces late mRNAs by discontinuous synthesis. Cell 50, 153-162.
4. Broyles, S. S. (2003). Vaccinia virus transcription. J Gen Virol 84, 2293-2303.
5. Broyles, S. S., Yuen, L., Shuman, S. & Moss, B. (1988). Purification of a factor required for transcription of vaccinia virus early genes. J Biol Chem 263, 10761-10765.
6. Broyles, S. S., Liu, X., Zhu, M. & Kremer, M. (1999). Transcription factor YY1 is a vaccinia virus late promoter activator. J Biol Chem 274, 35662-35667.
7. Broyles, S. S., Kremer, M. & Knutson, B. A. (2004). Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis. J Virol 78, 2137-2141.
8. Burley, S. K. & Roeder, R. G. (1996). Biochemistry and structural biology of transcription factor IID (TFIID). Annu Rev Biochem 65, 769-799.
9. Davison, A. J. & Moss, B. (1989). Structure of vaccinia virus late promoters. J Mol Biol 210, 771-784.
10. Galvin, K. M. & Shi, Y. (1997). Multiple mechanisms of transcriptional repression by YY1. Mol Cell Biol 17, 3723-3732.
11. Gordon, S., Akopyan, G., Garban, H. & Bonavida, B. (2006). Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25, 1125-1142.
12. Houbaviy, H. B., Usheva, A., Shenk, T. & Burley, S. K. (1996). Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc Natl Acad Sci U S A 93, 13577-13582.
13. Katsafanas, G. C. & Moss, B. (2004). Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated protein (p137) individually or as a heterodimer. J Biol Chem 279, 52210-52217.
14. Keck, J. G., Baldick, C. J., Jr & Moss, B. (1990). Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell 61, 801-809.
15. Kim, J. & Shapiro, D. J. (1996). In simple synthetic promoters YY1-induced DNA bending is important in transcription activation and repression. Nucleic Acids Res 24, 4341-4348.
16. Knutson, B. A., Liu, X., Oh, J. & Broyles, S. S. (2006). Vaccinia virus intermediate and late promoters are targeted by the TATA binding protein. J Virol 80, 6784-6793.
17. Kovacs, G. R. & Moss, B. (1996). The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. J Virol 70, 6796-6802.
18. Leirdal, M. & Sioud, M. (2002). Gene silencing in mammalian cells by preformed small RNA duplexes. Biochem Biophys Res Commun 295, 744-748.
19. Liu, X., Kremer, M. & Broyles, S. S. (2004). A natural vaccinia virus promoter with exceptional capacity to direct protein synthesis. J Virol Methods 122, 141-145.
20. Miller, J. H. (1972). Assay of β-galactosidase. In Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
21. Natesan, S. & Gilman, M. Z. (1993). DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev 7, 2497-2509.
22. Oh, J. & Broyles, S. S. (2005). Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes. J Virol 79, 12852-12860.
23. Rosales, R., Harris, N., Ahn, B. Y. & Moss, B. (1994a). Purification and identification of a vaccinia virus-encoded intermediate stage promoter-specific transcription factor that has homology to eukaryotic transcription factor SII (TFIIS) and an additional role as a viral RNA polymerase subunit. J Biol Chem 269, 14260-14267.
24. Rosales, R., Sutter, G. & Moss, B. (1994b). A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proc Natl Acad Sci U S A 91, 3794-3798.
25. Sanz, P. & Moss, B. (1999). Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression. Proc Natl Acad Sci U S A 96, 2692-2697.
26. Schwer, B., Visca, P., Vos, J. C. & Stunnenberg, H. G. (1987). Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5′ poly(A) leader. Cell 50, 163-169.
27. Seto, E., Shi, Y. & Shenk, T. (1991). YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 354, 241-245.
28. Shi, Y., Seto, E., Chang, L. S. & Shenk, T. (1991). Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67, 377-388.
29. Thomas, M. J. & Seto, E. (1999). Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236, 197-208.
30. Tyagi, R., Lai, R. & Duggleby, R. G. (2004). A new approach to 'megaprimer' polymerase chain reaction mutagenesis without an intermediate gel purification step. BMC Biotechnol 4, 2.
31. Wright, C. F., Oswald, B. W. & Dellis, S. (2001). Vaccinia virus late transcription is activated in vitro by cellular heterogeneous nuclear ribonucleoproteins. J Biol Chem 276, 40680-40686.
32. Zhu, M., Moore, T. & Broyles, S. S. (1998). A cellular protein binds vaccinia virus late promoters and activates transcription in vitro. J Virol 72, 3893-3899.